Cyclacel Pharma (CYCC) Reports Q1 Loss Per Share of $0.19
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.19), versus ($0.25) reported last year. Revenue for the quarter came in at $512 thousand, versus $396 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
